Trial Profile
Official Title: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Adding Methotrexate to ZORCELL in Subjects With Moderate to Severe Plaque Psoriasis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 10 Dec 2013
Price :
$35
*
At a glance
- Drugs Psoriasis vaccine (Primary) ; Methotrexate
- Indications Plaque psoriasis
- Focus Therapeutic Use
- Sponsors Immune Response BioPharma
- 10 Dec 2013 New trial record